Abstract:
PURPOSE: A composition for anti-inflammation and immunity regulation is provided to suppress expression of TNF-alpha and prostaglandin(PGE2) and to teat inflammatory diseases. CONSTITUTION: A composition for anti-inflammation and enhancing immunity contains trisnorhopanone, campesterol, and diplopterol as an active ingredient. The active ingredient suppresses NO generation and TNF-alpha generation. The active ingredient further contains dryocrassin, dryocrassol, dryocrassyl acetate, fernene, or flavaspidic acid.
Abstract:
PURPOSE: A composition containing Codonopis lanceolata extract or Codonopis lanceolata saponin is provided to prevent hair loss or to promote hair growth. CONSTITUTION: A composition for promoting hair growth contains Codonopis lanceolata extract as an active ingredient. The Codonopis lanceolata extract is saponin fraction of Codonopis lanceolata. The composition contains Codonopis lanceolata saponin as an active ingredient. An external use skin formulation for hair growth containing the composition is used in the form of scalp treatment, soap, hair tonic, shampoo, rinse, hair pack, lotion conditioner, hair oil, cream, soild formulation, dispersing agent, liposome or ointment.
Abstract:
본 발명은 더덕 추출물 또는 더덕의 사포닌을 유효성분으로 포함하는 발모 또는 양모 촉진용 조성물 및 이를 포함하는 피부외용제 또는 기능성 식품에 관한 것이다. 본 발명은 또한 더덕 추출물 또는 더덕의 사포닌을 유효성분으로 포함하는 조성물을 사용하여 발모 또는 양모를 촉진하는 방법을 제공한다. 본 발명의 조성물 및 이를 함유하는 제품은 사람 뿐만 아니라 애완동물이나, 털을 채취하거나 모피를 이용하는 동물에 적용할 수 있다. 더덕, 사포닌, 발모, 양모
Abstract:
PURPOSE: An anticancer composition containing kojic acid derivative compounds is provided to suppress glioma proliferation and to prevent and treat glioma-derived tumor. CONSTITUTION: An anticancer composition contains kojic acid derivative of chemical formula 1 or 2 as an active ingredient. The compound of chemical formula 1 is 5-hydroxy-2-((2-((5-hydroxy-4-oxo-4H-pyrane-2-yl)methylthio)phenylthio)methyl)-4H-pyrane-4-one. The compound of chemical formula 2 is -(((2-(((5-hydroxy-4-oxo-4H-pyran-2-yl)methyl)sulfanyl)ethyl) sulfanyl)methyl)-4H-pyran-4-one of chemical formula 3 or 5-hydroxy-2-(((2-(((5-hydroxy-4-oxo-4H-pyran-2-yl)methyl)sulfanyl) propyl)sulfanyl)methyl)-4H-pyran-4-one of chemical formula 4.
Abstract:
PURPOSE: A composition containing Codonopis lanceolata extract or Codonopis lanceolata saponin is provided to prevent or treat diseases or symptom caused by excessive histamine secretion. CONSTITUTION: A composition for suppressing histamine secretion contains Codonopis lanceolata or Codonopis lanceolata saponin as an active ingredient. A composition for preventin or treating disease or symptom caused by excessive histamine secretion contains Codonopis lanceolata or Codonopis lanceolata saponin as an active ingredient. The diseases or symptom caused by excessive histamine secretion is pruritus, rhinorrhea, nasal obstruction, idle talk increase, chest pressure feeling, respiratory distress, circulating machine, and hypotension. A pharmaceutical composition for preventing or treating pruritus contains Codonopis lanceolata saponin as an active ingredient.
Abstract:
PURPOSE: A mobile terminal-based multiple control system and a method thereof are provided to construct a Bluetooth network between a mobile terminal and a central control device and a Zigbee network between the central control device and devices, thereby remotely controlling home appliances in various places. CONSTITUTION: A CPU(Central Processing Unit) (20) comprises a Bluetooth access point (24), a Zigbee application (32), a signal converter (28), and a Zigbee router (30). The signal converter converts a Bluetooth signal outputted from the Bluetooth access point into a Zigbee signal and outputs the Zigbee signal. The Zigbee router transmits the Zigbee signal outputted from the signal converter. Each of multiple devices (40-1~40-n) comprises a Zigbee end device. The Zigbee end device receives the Zigbee signal from the Zigbee router and executes the Zigbee signal. [Reference numerals] (10) Mobile terminal; (14) Bluetooth module; (16) Bluetooth application; (20) Central processing unit; (24) Bluetooth access point; (26) Bluetooth program; (28) Signal converter; (30) Zigbee router; (32) Zigbee application; (40-1,40-2,40-n) Device, Zigbee end device
Abstract:
본 발명은 코지산(kojic acid) 유도체 화합물을 유효성분으로 함유하는 항암용 조성물에 관한 것이다. 본 발명에 따른 코지산 유도체 화합물은 Src계 키나아제 활성을 억제함으로써 신경교종(glioma) 세포의 증식을 저해하고, 대식세포에서의 TLR4 매개 활성을 억제하는 효과가 우수하여 신경교종 유래의 종양에 대한 치료 및 예방에 유용하게 사용될 수 있다. 코지산 유도체, 신경교종, Src 키나아제, 대식세포, 세포증식, 종양
Abstract:
PURPOSE: A composition containing Hopea odorata Roxb. extract with anti-inflammation is provided to control macrophage function and to prevent and treat acure/chronic inflammation immunity and autoimmune response. CONSTITUTION: A pharmaceutical composition contains Hopea odorata Roxb. extract as an active ingredient. The extract is isolated using methanol, ethanol, or water. The extract is prepared by isolating Hopea odorata Roxb. with ethanol, suspending with water, and fractioning with n-hexane, ethyl acetate, and n-butanol. The extract is prepared in the form of a carrier, excipient, or diluent. The extract suppresses NO generation and pro-inflammatory cytokines(IL-6, GM-CSF, IL-1β and TNF-alpha). A neutraceutical food contains the hot water extract of Hopea odorata Roxb. as an active ingredient.
Abstract:
본 발명은 더덕 추출물 또는 더덕 사포닌을 유효성분으로 포함하는 비만세포로부터 히스타민의 분비를 억제하는 효과를 갖는 조성물에 관한 것이다. 본 발명의 조성물과 이를 포함하는 제품은 소양증을 비롯하여 발적, 화끈거리는 열감, 두드러기, 재채기, 맑은 콧물, 코막힘, 객담증가, 흉부압박감, 호흡곤란, 순환기계의 빈맥, 저혈압, 전신 무기력증, 어지러움증과 같은 히스타민의 필요이상의 분비로 인하여 발생되는 질병이나 증상의 예방 또는 치료용도로 사용될 수 있다. 본 발명의 조성물 및 이를 함유하는 제품은 사람뿐만 아니라 동물에도 적용할 수 있다. 더덕, 사포닌, 소양증, 비만세포, 탈과립, 히스타민